Literature DB >> 35530276

Low HECTD1 mRNA expression is associated with poor prognosis and may be correlated with increased mitochondrial respiratory function in breast cancer.

Yasuaki Uemoto1, Eriko Katsuta2, Naoto Kondo1, Yumi Wanifuchi-Endo1, Takashi Fujita1, Tomoko Asano1, Tomoka Hisada1, Mitsuo Terada1, Akiko Kato1, Katsuhiro Okuda3, Hiroshi Sugiura4, Masayuki Komura5, Hiroyuki Kato5, Satoshi Osaga6, Satoru Takahashi5, Tatsuya Toyama1.   

Abstract

HECT domain E3 ubiquitin ligase 1 (HECTD1) has been reported to be a negative regulator of epithelial-mesenchymal transition and to decrease breast cancer invasion and metastasis. However, the clinical significance and detailed role of HECTD1 in breast cancer remain elusive. We investigated the role of HECTD1 in two large breast cancer cohorts at our institution and The Cancer Genome Atlas using mRNA expression and bioinformatics analysis. We also examined the prognostic significance of HECTD1 mRNA expression by multivariate analysis and HECTD1 protein expression by immunohistochemistry using our cohort. HECTD1 mRNA expression was significantly lower in breast cancer tissues compared with those in adjacent normal tissues (P<0.001). HECTD1 mRNA expression levels also differed among breast cancer subtypes. Decreased HECTD1 mRNA expression was significantly associated with aggressive tumor characteristics, including large tumor size and high histological grade. HECTD1 mRNA expression was inversely associated with mitochondrial cellular respiratory function (oxidative phosphorylation (P<0.001, FDR q-value <0.001) the respiratory chain complex (P<0.001, FDR q-value <0.001) and reactive oxygen species (P<0.001, FDR q-value <0.001), but not with epithelial-mesenchymal transition, in breast cancer tissues. Low expression of HECTD1 mRNA was associated with shorter disease-free survival (log-rank: P=0.013) and overall survival (log-rank: P=0.038) in breast cancer patients. Multivariate analysis also identified low HECTD1 mRNA expression level as an independent risk factor for disease-free (hazard ratio: 1.54, 95% confidence interval: 1.11-2.13, P=0.009) and overall (hazard ratio: 1.50, 95% confidence interval: 1.01-2.24, P=0.046) survival among breast cancer patients. There was no association of HECTD1 protein expression with HECTD1 mRNA expression and prognosis. In conclusion, we identified low expression of HECTD1 mRNA as an independent poor prognostic factor in breast cancer and showed that HECTD1 mRNA expression was inversely correlated with genes involved in mitochondrial cellular respiratory function in breast cancer. AJCR
Copyright © 2022.

Entities:  

Keywords:  Breast cancer; HECTD1; mitochondrial respiration; prognostic factor

Year:  2022        PMID: 35530276      PMCID: PMC9077061     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   5.942


  33 in total

1.  Concordance among gene-expression-based predictors for breast cancer.

Authors:  Cheng Fan; Daniel S Oh; Lodewyk Wessels; Britta Weigelt; Dimitry S A Nuyten; Andrew B Nobel; Laura J van't Veer; Charles M Perou
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

Review 2.  On the Dependency of Cellular Protein Levels on mRNA Abundance.

Authors:  Yansheng Liu; Andreas Beyer; Ruedi Aebersold
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

3.  Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients.

Authors:  Mayumi Nishimoto; Sayaka Nishikawa; Naoto Kondo; Yumi Wanifuchi-Endo; Yukari Hato; Tomoka Hisada; Yu Dong; Katsuhiro Okuda; Hiroshi Sugiura; Hiroyuki Kato; Satoru Takahashi; Tatsuya Toyama
Journal:  Jpn J Clin Oncol       Date:  2019-06-01       Impact factor: 3.019

4.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Authors:  J M Harvey; G M Clark; C K Osborne; D C Allred
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

Review 5.  Regulation of translation initiation in eukaryotes: mechanisms and biological targets.

Authors:  Nahum Sonenberg; Alan G Hinnebusch
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

Review 6.  Mitochondria and Cancer.

Authors:  Wei-Xing Zong; Joshua D Rabinowitz; Eileen White
Journal:  Mol Cell       Date:  2016-03-03       Impact factor: 17.970

7.  The E3 Ubiquitin Ligase HectD1 Suppresses EMT and Metastasis by Targeting the +TIP ACF7 for Degradation.

Authors:  Stéphanie Duhamel; Marie-Anne Goyette; Marie-Pier Thibault; Dominic Filion; Louis Gaboury; Jean-François Côté
Journal:  Cell Rep       Date:  2018-01-28       Impact factor: 9.423

8.  Ubiquitylation of phosphatidylinositol 4-phosphate 5-kinase type I γ by HECTD1 regulates focal adhesion dynamics and cell migration.

Authors:  Xiang Li; Qi Zhou; Manjula Sunkara; Matthew L Kutys; Zhaofei Wu; Piotr Rychahou; Andrew J Morris; Haining Zhu; B Mark Evers; Cai Huang
Journal:  J Cell Sci       Date:  2013-04-09       Impact factor: 5.285

9.  Low RAI2 expression is a marker of poor prognosis in breast cancer.

Authors:  Sayaka Nishikawa; Yasuaki Uemoto; Tae-Sun Kim; Tomoka Hisada; Naoto Kondo; Yumi Wanifuchi-Endo; Takashi Fujita; Tomoko Asano; Yusuke Katagiri; Mitsuo Terada; Akiko Kato; Yu Dong; Hiroshi Sugiura; Katsuhiro Okuda; Hiroyuki Kato; Satoshi Osaga; Satoru Takahashi; Tatsuya Toyama
Journal:  Breast Cancer Res Treat       Date:  2021-03-29       Impact factor: 4.872

10.  Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.

Authors:  Betsy A Kohler; Recinda L Sherman; Nadia Howlader; Ahmedin Jemal; A Blythe Ryerson; Kevin A Henry; Francis P Boscoe; Kathleen A Cronin; Andrew Lake; Anne-Michelle Noone; S Jane Henley; Christie R Eheman; Robert N Anderson; Lynne Penberthy
Journal:  J Natl Cancer Inst       Date:  2015-03-30       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.